Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.

Sano M, Raman R, Emond J, Thomas RG, Petersen R, Schneider LS, Aisen PS.

Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):122-7. doi: 10.1097/WAD.0b013e3181f883b7.

2.

Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.

Podhorna J, Krahnke T, Shear M, Harrison JE; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2016 Feb 12;8:8. doi: 10.1186/s13195-016-0170-5.

3.

Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial.

Sevigny JJ, Peng Y, Liu L, Lines CR.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):119-24. doi: 10.1177/1533317509350298.

PMID:
19949163
5.

The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials.

Raghavan N, Samtani MN, Farnum M, Yang E, Novak G, Grundman M, Narayan V, DiBernardo A; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Feb;9(1 Suppl):S21-31. doi: 10.1016/j.jalz.2012.05.2187. Epub 2012 Nov 2.

6.

Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.

Irizarry MC, Webb DJ, Bains C, Barrett SJ, Lai RY, Laroche JP, Hosford D, Maher-Edwards G, Weil JG.

J Alzheimers Dis. 2008 Jul;14(3):301-11.

PMID:
18599956
7.
8.

The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.

Skinner J, Carvalho JO, Potter GG, Thames A, Zelinski E, Crane PK, Gibbons LE; Alzheimer's Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Dec;6(4):489-501. doi: 10.1007/s11682-012-9166-3.

9.

Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.

Ihl R, Ferris S, Robert P, Winblad B, Gauthier S, Tennigkeit F.

Int J Geriatr Psychiatry. 2012 Jan;27(1):15-21. doi: 10.1002/gps.2679. Epub 2011 Mar 8.

PMID:
21384431
10.

Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.

Karin A, Hannesdottir K, Jaeger J, Annas P, Segerdahl M, Karlsson P, Sjögren N, von Rosen T, Miller F.

Acta Neurol Scand. 2014 Feb;129(2):114-22. doi: 10.1111/ane.12153. Epub 2013 Jun 13.

PMID:
23763450
11.

Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials.

Bernick C, Cummings J, Raman R, Sun X, Aisen P.

Arch Neurol. 2012 Jul;69(7):901-5.

PMID:
22431834
12.

The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.

Pyo G, Elble RJ, Ala T, Markwell SJ.

Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):16-22.

PMID:
16493231
13.

The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.

Rozzini L, Vicini Chilovi B, Bertoletti E, Conti M, Delrio I, Trabucchi M, Padovani A.

J Geriatr Psychiatry Neurol. 2008 Dec;21(4):261-7. doi: 10.1177/0891988708324940.

PMID:
19017783
15.

[Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer's disease: data on NORMACODEM project].

Monllau A, Pena-Casanova J, Blesa R, Aguilar M, Bohm P, Sol JM, Hernandez G.

Neurologia. 2007 Oct;22(8):493-501. Spanish.

PMID:
17602338
16.

Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.

Lam LC, Tam CW, Lui VW, Chan WC, Chan SS, Chiu HF, Leung T, Tham MK, Ho KS, Chan WM.

Neuroepidemiology. 2008;30(1):6-12. doi: 10.1159/000113300. Epub 2008 Jan 17.

PMID:
18204291
17.

Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease.

Llano DA, Laforet G, Devanarayan V; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):73-84. doi: 10.1097/WAD.0b013e3181f5b8d8.

PMID:
20847637
18.

The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.

Doraiswamy PM, Kaiser L, Bieber F, Garman RL.

Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):174-83. Erratum in: Alzheimer Dis Assoc Disord 2002 Jan-Mar;16(1):48.

PMID:
11723368
19.

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.

Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ; Alzheimer's Disease Cooperative Study.

Neurology. 2007 May 8;68(19):1588-95. Epub 2007 Feb 7.

PMID:
17287448

Supplemental Content

Support Center